Clinical trials
Completed Phase 1 Lymphoproliferative Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2007 | 3 |
| 2008 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seagen Inc. | 4 |
| Baylor College of Medicine | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| AVEO Pharmaceuticals, Inc. | 1 |
| Cancer Research UK | 1 |
| Children's Oncology Group | 1 |
| DEKK-TEC, Inc. | 1 |
| Eisai Co., Ltd. | 1 |
| M.D. Anderson Cancer Center | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoproliferative Disorders | 21 |
| Lymphoma | 11 |
| Lymphoma, Non-Hodgkin | 9 |
| Hodgkin Disease | 8 |
| Immunoproliferative Disorders | 6 |
| Lymphatic Diseases | 6 |
| Lymphoma, Large B-Cell, Diffuse | 6 |
| Burkitt Lymphoma | 5 |
| Hematologic Diseases | 5 |
| Immunoblastic Lymphadenopathy | 5 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.